Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Codexis Inc (NQ: CDXS )

3.500 +0.360 (+11.46%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Codexis Inc

< Previous 1 2 3 Next >
Earnings Outlook For Codexis
Codexis (NASDAQ:CDXS) is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement. Analysts estimate that Codexis will report... 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  Thursday saw 177 companies set new 52-week lows. 
Via Benzinga
Analyst Ratings for Codexis
  Codexis (NASDAQ:CDXS) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Codexis: Q2 Earnings Insights
Codexis (NASDAQ:CDXS) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Codexis beat estimated earnings by... 
Via Benzinga
US Stock Futures Higher Ahead of J&J, Netflix Earnings
Pre-open movers 
Via Benzinga
Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading higher this morning on Tuesday ahead of earnings reports from several companies, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Codexis Shares Slide On CEO Transition
Via Benzinga
Why Codexis Shares Are Slumping Today
Via Benzinga
Why Bank Stocks Traded Sharply Higher; Here's 65 Biggest Movers From Friday
Gainers United Maritime Corporation (NASDAQ: USEA) shares climbed 175.9% to close at $6.07 on Friday. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering... 
Via Benzinga
Crude Oil Rises By More Than 2%; Codexis Shares Plummet
U.S. stocks traded higher toward the end of trading, following the release of several earnings results and economic reports. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
  
Via Benzinga
Dow Jumps More Than 600 Points; Citigroup Tops Q2 Expectations
U.S. stocks traded higher midway through trading, following the release of several earnings results and economic reports. 
Via Benzinga
Why U.S. Stocks Are Trading Higher; Retail Sales Rise This Much In June
U.S. stocks traded higher this morning, following the release of several earnings results and economic reports. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
  
Via Benzinga
Citigroup, Bank of America And 48 Stocks Moving In Friday's Mid-Day Session
Gainers United Maritime Corporation (NASDAQ: USEA) shares jumped 180.9% to $6.19. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on Wednesday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning! We're starting the last day of trading this week with a breakdown of the biggest pre-market stock movers for Friday! 
Via InvestorPlace
Why Is Pinterest Higher By 14%? 20 Stocks Moving In Friday's Pre-Market Session
Gainers United Maritime Corporation (NASDAQ: USEA) rose 55% to $3.41 in pre-market trading. United Maritime, on Tuesday, announced acquisition of four oil tankers and filed for stock offering on... 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle... 
Via Benzinga
Codexis and seqWell Announce Strategic Investment and Partnership Initiation
From seqWell
Via Business Wire
Codexis: Q4 Earnings Insights
Codexis (NASDAQ:CDXS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Codexis... 
Via Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (... 
Via Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front... 
Via Benzinga
3 Synthetic Biology Stocks In Focus With Strong Potential
Here we discuss three stocks engaged in the field of scientific biology that investors must follow, as they have the potential to generate wealth going forward. 
Via Talk Markets
Top Biotech Stocks: Trading Opportunities For Next Week
A security pattern traces the distinct movements of prices, which helps traders make informed trading decisions. Let's look at some biotech stock opportunities by analyzing these patterns. 
Via Talk Markets
64 Stocks Moving In Friday's Mid-Day Session
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares climbed 198.4% to $14.92. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the middle of the... 
Via Benzinga
92 Biggest Movers From Friday
Gainers Mainz Biomed B.V. (NASDAQ: MYNZ) shares jumped 99.8% to close at $9.99 on Friday. Mainz Biomed priced its initial public offering of 2 million ordinary shares at $5, the... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Ontrak (NASDAQ:OTRK) shares rose 21.82% to $11.78 during Friday's pre-market session. The market value of their outstanding shares is at $225.5 million. As per... 
Via Benzinga
Codexis Inc (CDXS) Q3 2021 Earnings Call Transcript
CDXS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Up Over 500% in the Last 5 Years, Can This Biotech Continue Its Hot Streak?
Codexis is leveraging its core technology to create more effective life science tools. 
Via The Motley Fool
Codexis, Merck Extend Supply Pact For Enzyme Used To Manufacture Sitagliptin
Codexis Inc (NASDAQ: CDXS) has amended and extended its agreement with Merck & Co Inc (NYSE: MRK) to license and supply a proprietary enzyme used to... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.